The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

Thu, 25th Apr 2024 09:12

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Amongst individual stocks, Anglo American shares jumped, after it confirmed that it was "reviewing" a takeover bid from its larger Australian rival BHP Group.

The FTSE 100 index opened up 33.81 points, 0.4%, at 8,074.19. The FTSE 250 was down 98.85 points, 0.5%, at 19,620.52, and the AIM All-Share was down 0.60 of a point, 0.1%, at 754.09.

The Cboe UK 100 was up 0.5% at 806.43, the Cboe UK 250 was down 0.5% at 16,979.96, and the Cboe Small Companies was down marginally at 15,317.25.

In European equities on Thursday, the CAC 40 in Paris was down 0.3%, while the DAX 40 in Frankfurt was down 0.1%.

All eyes are on US economic data. Thursday's economic calendar has a gross domestic product reading at 1330 BST.

"A strong GDP reading would suggest that the US economy is sufficiently strong to support corporate earnings, but it could also delay expectations for a Fed rate cut. Conversely, a softer-than-expected GDP figure would likely increase expectations for a rate cut, especially if earnings disappoint due to inflated expectations," said Ipek Ozkardeskaya at Swissquote Bank.

"Overall, I believe that a softer-than-expected GDP would elicit a more positive market reaction, but the risks surrounding GDP lean towards a better-than-expected reading."

After the GDP reading, attention will quickly turn to personal consumption expenditure data, which is the Fed's preferred gauge of inflation.

Friday's US PCE reading is expected to show the annual core PCE inflation measure eased to 2.6% in March from 2.8% in February.

The pound was quoted at USD1.2491 early on Thursday in London, higher compared to USD1.2432 at the equities close on Wednesday. The euro stood at USD1.0714, higher against USD1.0687. Against the yen, the dollar was trading at JPY155.65, up compared to JPY155.06.

In the FTSE 100, Anglo American took the spotlight, jumped 13%.

The miner confirmed that it was "reviewing" a takeover bid from its larger Australian rival BHP Group, in what would rank as one of the sector's biggest deals in years.

Anglo American did not disclose the price of the "unsolicited" offer, which must be sewn up before a deadline of May 22.

However, BHP subsequently said the offer values Anglo American's share capital at GBP31.1 billion.

Australian-based BHP has a market value of around USD148 billion, while London-based Anglo American has a market value of about USD36 billion.

AstraZeneca rose 5.3%.

The pharmaceutical firm reported that revenue rose to USD12.68 billion in the first quarter of 2024, up 17% from USD10.88 billion a year earlier. Pretax profit jumped to USD2.80 billion from USD2.62 billion.

On the back of the results, Astra upped its dividend to USD3.10 from USD2.90.

In the FTSE 250, Inchcape edged 5.3% higher.

The London-based automotive distributor said revenue rose 5% on a reported basis to GBP2.3 billion in the first quarter of 2024. On an organic basis, the figure edged up 6% and at constant FX rates was 11% higher.

"Our positive start to 2024 reflects the underlying quality of our business and we have confidence in, and we have reiterated, our outlook for the year," said Chief Executive Duncan Tait.

On the other hand, WH Smith lost 7.5%.

The London-based retailer, which operates on UK high streets and travel locations like airports and train stations globally, said revenue rose 8% to GBP926 million in the six months ended February 29, from GBP859m a year earlier.

Pretax profit, however, fell to GBP28 million from GBP45 million.

Looking ahead, WH Smith said it is on track to deliver full year results in line with expectations.

CEO Carl Cowling said: "The group is in its strongest ever position as a global travel retailer. We have had a good first half and our businesses are well positioned for the peak summer trading period."

In the US on Wednesday, stocks on Wall Street were muted, with the Dow Jones Industrial Average closing down 0.1%, the S&P 500 rising marginally, and the Nasdaq Composite adding 0.1%.

After the closing bell in New York, Meta Platforms plunged 15% in after-hours trading.

Meta signalled higher-than-expected costs lay ahead as it ploughs more cash into artificial intelligence after reporting another bumper quarter.

The owner of Facebook and Instagram reported a double-digit increase in quarterly revenue, while profit more than doubled year-on-year in the first quarter. However, it increased guidance for full-year total expenses and capital expenditures, and warned that operating losses at Reality Labs would increase "meaningfully".

Alphabet, Intel, and Microsoft are all due to report earnings on Thursday.

In Asia on Thursday, the Nikkei 225 index in Tokyo was down 2.2%. In China, the Shanghai Composite was up 0.3%, while the Hang Seng index in Hong Kong was up 0.4%.

In Sydney, financial markets were closed for Anzac Day.

Brent oil was quoted at USD88.21 a barrel early in London on Thursday, up from USD88.12 late Wednesday.

Gold was quoted at USD2,320.70 an ounce, lower against USD2,329.42.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.